Cite
HARVARD Citation
Jones, D. (2018). Non-clinical aspects of oligonucleotide drug development: A regulator's perspective. Toxicology letters. pp. S23-S24. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jones, D. (2018). Non-clinical aspects of oligonucleotide drug development: A regulator's perspective. Toxicology letters. pp. S23-S24. [Online].